Cyclophosphamide independently enhances daratumumab-mediated killing of MM cells by altering the tumor microenvironment to promote macrophage recruitment, polarization to a pro-inflammatory phenotype, and directing ADCP. Hence, scientific tests that centered on combining macropinocytosis inhibitors with other metabolic pathway inhibitors could improve cancers therapeutic outcomes. Thi... https://shulamithx964pua7.mysticwiki.com/user